Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.155 CAD | 0.00% | 0.00% | +55.00% |
Apr. 18 | Entheon Biomedical Corp. announced that it has received CAD 0.1475 million in funding | CI |
Apr. 11 | Entheon Biomedical Corp. announced that it expects to receive CAD 0.1475 million in funding | CI |
Sales 2022 | 0.19 0.26 | Sales 2023 | 0.25 0.34 | Capitalization | 591K 806K |
---|---|---|---|---|---|
Net income 2022 | -8M -10.92M | Net income 2023 | - 0 | EV / Sales 2022 | 5,759,850 x |
Net cash position 2022 | 680K 928K | Net cash position 2023 | 345K 470K | EV / Sales 2023 | 983,765 x |
P/E ratio 2022 |
-0.21
x | P/E ratio 2023 |
-1.97
x | Employees | 2 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 97.86% |
Current month | -22.50% | ||
1 month | +40.91% | ||
3 months | +55.00% | ||
6 months | +55.00% | ||
Current year | +55.00% |
Managers | Title | Age | Since |
---|---|---|---|
Timothy Ko
CEO | Chief Executive Officer | 39 | 19-06-30 |
Soo-Whan Kim
DFI | Director of Finance/CFO | - | 23-01-06 |
Andrew Hegle
BRD | Director/Board Member | 46 | 19-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Timothy Ko
CEO | Chief Executive Officer | 39 | 19-06-30 |
Andrew Hegle
BRD | Director/Board Member | 46 | 19-12-31 |
Director/Board Member | 53 | 20-11-04 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.155 | -22.50% | 500 |
24-04-24 | 0.2 | -13.04% | 53,817 |
24-04-22 | 0.23 | +43.75% | 1,600 |
24-04-19 | 0.16 | +3.23% | 29,200 |
24-04-18 | 0.155 | +3.33% | 105,000 |
Delayed Quote Canadian Securities Exchange, April 25, 2024 at 02:03 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+55.00% | 1M | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+46.73% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- ENBI Stock